Dr. Benjamin L. Schlechter, MD

Dr. Schlechter is Senior Physician in the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute with a particular focus on colorectal cancer, anal cancer, and innovative immunotherapies. He previously worked in the laboratory of Dr. Carol L. Rosenberg at Boston University School of Medicine and Dr. Donald E. Ingber at the Wyss Institute at Harvard University. Dr. Schlechter is a former member of the faculty of Beth Israel Deaconess Medical Center as well as the former Director of Inpatient Hematology and Oncology there. He is an active participant in investigator-initiated, cooperative group, and industry funded clinical trials in GI malignancies. He currently focuses on the development of novel approaches to immunotherapy in GI cancers generally and colorectal cancer in particular. He is the Harvard-wide principal investigator of several cellular therapy trials for GI cancers as well as trials involving checkpoint inhibitors and novel chemotherapies.